
Doubling of LFB'S BIOPRODUCTION CAPACITY AT ALÈS WITH THE SUPPORT OF “FRANCE 2030”

2023 edition of the LFB corporate brochure

Discover the interview with Jacques Brom, CEO of LFB

LFB BIOMANUFACTURING JOINS FRANCE BIOLEAD

LFB bioproduction site in Alès: discover in pictures the multi-product industrial site

Discover the LFB series "The Powers of Blood"

4th vidéo episod : the new LFB Arras plant, November 2022

LFB announces the approval of CEVENFACTA® in the European Union
in 2022.
BIOPRODUCTION SITES in the world
IN THE FIELD OF PLASMA-DERIVED MEDICINAL PRODUCTS
prescribed to
hospital
of LFB’s biomedicinal products are intended for the treatment of patients with rare diseases
- Immunology
- Haemostasis
- Intensive Care

5:31
Interview with Jacques Brom, June 2023
there is 5 months

1:43
"The Powers of Blood" series: épisode 2 “What is Plasma?"
there is 10 months

4:17
November 2022: new LFB Arras plant
there is 11 months

5:01
The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites
there is 1 year